WPD Pharmaceuticals Inc.
WPD Pharmaceuticals Inc.
WPD Pharmaceuticals is a biotechnology research and development company. The Company operates in the pharmaceuticals industry with a focus on oncology, namely research and development of medicinal products involving biological compounds and small molecules. The Issuer is developing drugs which were researched at institutions including MD Anderson Cancer Center, Mayo Clinic and Emory University, and has ongoing collaborations with Wake Forest University and leading hospitals and academic centers in Poland.
WPD Pharmaceuticals Inc. (WBIO)
SEDAR Information
Company Info
Capitalization
News Releases
Bulletins
2024-0524 - Reinstatement - WPD Pharmaceuticals Inc. (WBIO)
le 24 mai/May 2024
Effective immediately, WPD Pharmaceuticals Inc. will be reinstated for trading.
The Company has rectified the situation that gave rise to the suspension.
____________________________
Avec effet immédiat, WPD Pharmaceuticals Inc. sera réintégrée à la négociation.
La Société a rectifié la situation qui a donné lieu à la suspension.
CSE Filings
